Apr 23, 2020 Apr 23, 2020 ProThera Biologics and Takeda Enter Global Licensing Agreement to Develop Novel Plasma-Derived Therapy Based on Inter-alpha Inhibitor Proteins (IAIP) GO TO THE NEWSROOM>